Chemotherapeutic agents drugs drug screening assays antitumor. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy14

Cell Line, Tumor Tumor Cells, Cultured Cell Line HCT116 Cells HT29 Cells HL-60 Cells K562 Cells Neoplastic Stem Cells KB Cells Cells, Cultured HeLa Cells Mitochondria Hep G2 Cells MCF-7 Cells

Organisms8

Mice, Nude Mice, Inbred BALB C Mice, SCID Mice, Inbred C57BL Adenoviridae Mice, Inbred C3H Rats, Nude Oncolytic Viruses

Diseases35

Neoplasms Neoplasms, Experimental Lung Neoplasms Breast Neoplasms Melanoma, Experimental Colonic Neoplasms Leukemia P388 Leukemia L1210 Melanoma Ovarian Neoplasms Sarcoma 180 Brain Neoplasms Pancreatic Neoplasms Adenocarcinoma Liver Neoplasms Mammary Neoplasms, Experimental Glioma Prostatic Neoplasms Fibrosarcoma Sarcoma, Experimental Osteosarcoma Neovascularization, Pathologic Carcinoma, Lewis Lung Glioblastoma Carcinoma, Hepatocellular Leukemia Neoplasm Metastasis Colorectal Neoplasms Disease Models, Animal Carcinoma, Non-Small-Cell Lung Neuroblastoma Carcinoma Carcinoma, Squamous Cell Bone Neoplasms Lymphoma

Chemicals and Drugs126

Antineoplastic Agents Doxorubicin Antibiotics, Antineoplastic Cisplatin Antineoplastic Agents, Phytogenic Paclitaxel Etoposide Fluorouracil Antineoplastic Agents, Alkylating Antimetabolites, Antineoplastic P-Glycoprotein Camptothecin Mitomycin Deoxycytidine Vincristine Dacarbazine Cyclophosphamide Tumor Suppressor Protein p53 Carmustine Proto-Oncogene Proteins c-bcl-2 Vinblastine Daunorubicin Caspases Taxoids Methotrexate Melphalan Bleomycin Enzyme Inhibitors Noscapine Prodrugs RNA, Small Interfering Apoptosis Regulatory Proteins Neoplasm Proteins Cancer Vaccines Antibodies, Monoclonal Tubulin Modulators Caspase 3 Poly(ADP-ribose) Polymerases bcl-X Protein Organoplatinum Compounds Drug Carriers Alkylating Agents Hycanthone Mitoxantrone Cytarabine Angiogenesis Inhibitors Thioguanine Radiation-Sensitizing Agents bcl-2-Associated X Protein Nitrogen Mustard Compounds Topotecan Protein Kinase Inhibitors Lomustine Topoisomerase I Inhibitors Nitrosourea Compounds Carboplatin Indoles RNA, Messenger Multidrug Resistance-Associated Proteins Pyrazines TNF-Related Apoptosis-Inducing Ligand Antigens, Neoplasm Topoisomerase II Inhibitors Zinostatin Boronic Acids Tetrazolium Salts Proto-Oncogene Proteins c-akt Tilorone Mitomycins Amsacrine Mechlorethamine Cardiotoxins Xanthones Quinazolines NF-kappa B Arsenicals Floxuridine DNA Topoisomerases, Type II DNA, Neoplasm Plant Extracts Naphthoquinones Thymidylate Synthase Receptors, TNF-Related Apoptosis-Inducing Ligand Gossypol Isocoumarins Proto-Oncogene Proteins Dioxoles Inhibitor of Apoptosis Proteins DNA Piperazines Platinum Immunotoxins Benzoquinones Thiazoles Recombinant Proteins Anthracyclines Pyrimidines Nanocapsules Oligonucleotides, Antisense ATP-Binding Cassette Transporters Stilbenes 6-Mercaptopurine Curcumin Guanine Enediynes Membrane Glycoproteins Nitroimidazoles Antibodies, Monoclonal, Humanized DNA-Binding Proteins Triterpenes Dactinomycin Tetrahydroisoquinolines Reactive Oxygen Species Dimetridazole X-Linked Inhibitor of Apoptosis Protein Teniposide Antiprotozoal Agents O(6)-Methylguanine-DNA Methyltransferase DNA Adducts Protein-Serine-Threonine Kinases Antimitotic Agents Tumor Necrosis Factor-alpha Imidazoles Liposomes Glutathione Hydroxamic Acids

Analytical, Diagnostic and Therapeutic Techniques and Equipment39

Drug Screening Assays, Antitumor Xenograft Model Antitumor Assays Neoplasm Transplantation Antineoplastic Combined Chemotherapy Protocols Neoplasms, Experimental Inhibitory Concentration 50 Melanoma, Experimental Transplantation, Heterologous Drug Delivery Systems Combined Modality Therapy Drug Evaluation, Preclinical Blotting, Western Flow Cytometry Immunotherapy Tumor Burden Transfection Genetic Therapy Drug Carriers Drug Administration Schedule Oncolytic Virotherapy Tumor Stem Cell Assay Mammary Neoplasms, Experimental Sarcoma, Experimental Reverse Transcriptase Polymerase Chain Reaction Injections, Intralesional Treatment Outcome Disease Models, Animal Immunohistochemistry In Situ Nick-End Labeling Drug Design Clinical Trials as Topic Immunotherapy, Adoptive Nanocapsules Injections, Intraperitoneal Subrenal Capsule Assay Molecular Targeted Therapy Lethal Dose 50 Models, Biological Colony-Forming Units Assay

Phenomena and Processes37

Drug Resistance, Neoplasm Apoptosis Drug Synergism Cell Survival Dose-Response Relationship, Drug Cell Proliferation Drug Resistance, Multiple Inhibitory Concentration 50 Cell Cycle Cell Division Gene Expression Regulation, Neoplastic DNA Damage Signal Transduction Drug Resistance Time Factors Cell Death Transfection Down-Regulation Cell Growth Processes Molecular Structure DNA Repair Drug Interactions Enzyme Activation Up-Regulation Genetic Vectors Phosphorylation RNA Interference Cytotoxicity, Immunologic Genes, p53 Gene Expression Structure-Activity Relationship DNA Fragmentation Cell Cycle Checkpoints Genes, MDR Lethal Dose 50 DNA Adducts G2 Phase

Disciplines and Occupations3

Immunohistochemistry Drug Design Nanomedicine

Technology, Industry, Agriculture4

Nanoparticles Nanomedicine Nanocapsules Liposomes

Information Science1

Molecular Sequence Data

Health Care2

Treatment Outcome Clinical Trials as Topic

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Health Care

Antineoplastic Agents Cell Line, Tumor Drug Screening Assays, Antitumor Doxorubicin Xenograft Model Antitumor Assays Drug Resistance, Neoplasm Apoptosis Antibiotics, Antineoplastic Cisplatin Drug Synergism Tumor Cells, Cultured Antineoplastic Agents, Phytogenic Neoplasms Mice, Nude Paclitaxel Cell Survival Etoposide Neoplasm Transplantation Fluorouracil Antineoplastic Agents, Alkylating Dose-Response Relationship, Drug Cell Proliferation Antineoplastic Combined Chemotherapy Protocols Neoplasms, Experimental Drug Resistance, Multiple Antimetabolites, Antineoplastic Inhibitory Concentration 50 P-Glycoprotein Lung Neoplasms Mice, Inbred BALB C Cell Cycle Camptothecin Mitomycin Deoxycytidine Vincristine Breast Neoplasms Melanoma, Experimental Transplantation, Heterologous Cell Division Dacarbazine Colonic Neoplasms Cyclophosphamide Tumor Suppressor Protein p53 Carmustine Leukemia P388 Proto-Oncogene Proteins c-bcl-2 Gene Expression Regulation, Neoplastic Mice, SCID DNA Damage Vinblastine Daunorubicin Leukemia L1210 Drug Delivery Systems Combined Modality Therapy Caspases Taxoids Drug Evaluation, Preclinical Blotting, Western Melanoma Flow Cytometry Methotrexate Ovarian Neoplasms Mice, Inbred C57BL Signal Transduction Drug Resistance Time Factors Cell Death Immunotherapy Melphalan Sarcoma 180 Bleomycin Tumor Burden Enzyme Inhibitors Noscapine Prodrugs Transfection RNA, Small Interfering Apoptosis Regulatory Proteins Neoplasm Proteins Cancer Vaccines Antibodies, Monoclonal Brain Neoplasms Tubulin Modulators Down-Regulation Genetic Therapy Caspase 3 Cell Line Poly(ADP-ribose) Polymerases bcl-X Protein Organoplatinum Compounds Drug Carriers Drug Administration Schedule Alkylating Agents Hycanthone Mitoxantrone Oncolytic Virotherapy Cell Growth Processes Adenoviridae HCT116 Cells Pancreatic Neoplasms

No FAQ available that match "chemotherapeutic agents drugs drug screening assays antitumor"